Perinatal Maternal Microbiome Perturbation Alters Metabolite Signaling and Microglial Responses in a Female Mouse model of Aβ amyloidosis

Maternal microbiome-dependent programming of neuroimmune and metabolic pathways during early development may critically shape sex-specific susceptibility to Alzheimer’s disease (AD) later in life. We have documented that in mouse models of Aβ deposition, broad-spectrum antibiotic (ABX)-mediated perturbations of the gut microbiome postnatally (P14-P21) selectively reduces Aβ pathology only in male, but not in female animals. Here, we shift the developmental window upstream to test whether perinatal maternal microbiome perturbations shapes the pathological trajectories of offspring. Dams were treated with the broad-spectrum ABX from preconception through gestation, without direct exposure of the offspring. Strikingly, maternal microbiome disruption selectively reduced cortical Aβ burden in female offspring, with no effect in males, effectively reversing the sex bias observed following postnatal ABX manipulations. To explore the mechanisms underlying this effect, we now report that female offspring exhibited coordinated shifts in microbial composition and amino acid metabolism, that are coupled to cortical transcriptional programs enriched for GPCR signaling and Rho GTPase pathways. As many microbial metabolites and amino acid-derived ligands signal through GPCRs that are expressed by microglia, these transcriptional changes suggest enhanced GPCR-mediated nutrient sensing in microglia of female animals. These systems level changes in microglia drive a metabolically engaged amyloid clearing phenotype, providing a mechanistic link between maternal microbiome disruption and enhanced Aβ clearance in females. Our study highlights developmental timing as an important determinant of microbiome-associated changes in microglial phenotypes and amyloid pathology in AD mice.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11613626/v1
Primary Topic
Alzheimer's disease research and treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Perinatal Maternal Microbiome Perturbation Alters Metabolite Signaling and Microglial Responses in a Female Mouse model of Aβ amyloidosis

Sangram S. Sisodia, Nicholas Slimmon, Piyali Saha, Priyam Patel et al.
2 links
Research Square
Alzheimer's disease research and treatments
preprint

Perinatal Maternal Microbiome Perturbation Alters Metabolite Signaling and Microglial Responses in a Female Mouse model of Aβ amyloidosis

Sangram S. Sisodia, Nicholas Slimmon, Piyali Saha, Priyam Patel, Pedro Blauth Poli, Diya Mishra, Ananya Nadgauda, Ana Inukai, Xiaoqiong Zhang, Ian Weigle, Ahtziri Fernandez
preprint en

Abstract

Maternal microbiome-dependent programming of neuroimmune and metabolic pathways during early development may critically shape sex-specific susceptibility to Alzheimer’s disease (AD) later in life. We have documented that in mouse models of Aβ deposition, broad-spectrum antibiotic (ABX)-mediated perturbations of the gut microbiome postnatally (P14-P21) selectively reduces Aβ pathology only in male, but not in female animals. Here, we shift the developmental window upstream to test whether perinatal maternal microbiome perturbations shapes the pathological trajectories of offspring. Dams were treated with the broad-spectrum ABX from preconception through gestation, without direct exposure of the offspring. Strikingly, maternal microbiome disruption selectively reduced cortical Aβ burden in female offspring, with no effect in males, effectively reversing the sex bias observed following postnatal ABX manipulations. To explore the mechanisms underlying this effect, we now report that female offspring exhibited coordinated shifts in microbial composition and amino acid metabolism, that are coupled to cortical transcriptional programs enriched for GPCR signaling and Rho GTPase pathways. As many microbial metabolites and amino acid-derived ligands signal through GPCRs that are expressed by microglia, these transcriptional changes suggest enhanced GPCR-mediated nutrient sensing in microglia of female animals. These systems level changes in microglia drive a metabolically engaged amyloid clearing phenotype, providing a mechanistic link between maternal microbiome disruption and enhanced Aβ clearance in females. Our study highlights developmental timing as an important determinant of microbiome-associated changes in microglial phenotypes and amyloid pathology in AD mice.

Research Square
University of Chicago (US), Northwestern Medicine (US), The University of Texas Southwestern Medical Center (US)
BrightFocus Foundation, Cure Alzheimer's Fund, Open Philanthropy Project, Good Ventures Foundation
Good health and well-being
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon